Radiation Oncology & Radiotherapy
A clinical overview of external beam modalities, stereotactic radiosurgery, proton therapy, brachytherapy, and image-guided treatment planning.
Overview
Radiation oncology utilizes precisely targeted ionizing photon, electron, or particle radiation to induce fatal double-strand DNA breaks in neoplastic tissue while preserving adjacent normal organs at risk (OAR). Radiotherapy is administered with curative intent (definitive), pre-operatively to downstage tumors (neoadjuvant), post-operatively to eliminate microscopic residual disease (adjuvant), or for rapid symptom palliation.
Primary Radiotherapy Modalities
| Modality |
Technical Mechanism |
Clinical Indication |
Key Advantages |
| Intensity-Modulated Radiation Therapy (IMRT / VMAT) |
Computer-controlled multileaf collimators (MLCs) modulate beam intensity dynamically during 360-degree rotational gantry arcs. |
Head and neck cancers, prostate carcinoma, gynecological and pelvic malignancies |
Highly conformal dose sculpting around concave structures; minimizes xerostomia and bowel toxicity |
| Stereotactic Radiosurgery & SBRT (SRS / SBRT) |
Ablative ultra-high doses delivered in 1 to 5 fractions using sub-millimeter stereotactic localization. |
Brain metastases, early-stage non-small cell lung cancer (NSCLC), oligometastatic lesions, spine metastases |
High local control rates (>90%); non-invasive alternative to surgical resection |
| Proton Beam Particle Therapy |
Charged heavy particles releasing peak ionization at a defined tissue depth (the Bragg Peak) with zero exit dose. |
Pediatric malignancies, skull base chordomas/chondrosarcomas, re-irradiation fields |
Significantly reduces integral radiation dose, lowering risks of secondary radiation-induced malignancies |
| Brachytherapy (Internal Sealed Source) |
Temporary (High-Dose-Rate - HDR) or permanent (Low-Dose-Rate - LDR) placement of sealed radioactive isotopes (Ir-192, I-125) inside or adjacent to tumor tissue. |
Cervical carcinoma, localized prostate cancer, accelerated partial breast irradiation |
Delivers intense localized radiation with rapid exponential fall-off to surrounding tissues |
7-Step Clinical Workflow & Treatment Pathway
- Consultation & Multidisciplinary Staging: Radiation oncologist reviews diagnostic imaging, pathology, and establishes treatment intent.
- CT Simulation & Immobilization: Fabrication of customized thermoplastic masks or body molds; acquisition of high-resolution 4D-CT simulation scans fused with diagnostic MRI/PET.
- Target & Organ-at-Risk Delineation: Delineating Gross Tumor Volume (GTV), Clinical Target Volume (CTV), Planning Target Volume (PTV), and critical OARs.
- Dosimetric Treatment Planning: Medical physicists and dosimetrists generate optimized inverse planning beam geometries and calculate 3D dose distributions.
- Physics Quality Assurance (QA): Phantom-based pre-treatment verification ensuring machine delivery matches calculated plan within 2-3% tolerance.
- Image-Guided Treatment Delivery (IGRT): Daily on-board cone-beam CT (CBCT) or surface-guided optical tracking ensuring sub-millimeter patient setup alignment.
- Survivorship & Toxicity Surveillance: Weekly on-treatment toxicity reviews and scheduled long-term surveillance.
Modern radiation oncology combines precision image guidance (IGRT) and computerized dose sculpting to maximize tumor eradication while protecting patient quality of life.